If approved, the next step will be revenue, and MSB bleeds cash especially when running trials.
ROFL .... so if the FDA granted Mesoblast an AA for CHF you don't think a global partnership deal for this indication would emerge with huge $$ ? Here's a reminder of how much money the last one saw deposited into Mesoblast's bank account and that was prior to the DREAM-HF phase 3 trial so one can only imagine what the size of said CHF partnership would be on the back of an FDA Accelerated Approval for Rexlemestrocel-L for CHF ..... the mind boggles
...... and I hate to burst your bubble but license fees / upfront payments for a partnership count as revenue so I think Mesoblast would be more than fine off the back of an FDA AA for CHF - just sayin'
https://www.fiercebiotech.com/biotech/cephalon-and-mesoblast-form-strategic-alliance
Cephalon and Mesoblast form strategic alliance
Under the terms of the Development and Commercialization Agreement between the companies, in exchange for exclusive world-wide rights to commercialize specific products based on Mesoblast's proprietary adult stem cell technology platform, Cephalon will make an upfront payment to Mesoblast totaling $130 million
In addition, under the terms of a Stock Purchase Agreement and a Subscription Deed, Cephalon will make an equity investment to purchase a 19.99% stake in Mesoblast at A$4.35 per share, totaling approximately $220 million. This price represents a 45% premium to the last 30 days' volume weighted average price for Mesoblast shares. Cephalon has entered into a standstill agreement to limit its investment to 19.99% of Mesoblast common stock for the next 12 months, with a right to maintain its equity stake on a top up basis, subject to the Australian Securities Exchange rules. Cephalon COO J. Kevin Buchi will join the Mesoblast Board of Directors, effective immediately.
https://www.biospace.com/article/re...ake-drug-rights-in-potential-2-billion-deal-/
Cephalon, Inc. Buys Mesoblast Limited Stake, Drug Rights in Potential $2 Billion Deal
Agreement Provides Cephalon with Global Rights in Three Treatment Areas to Products Derived from Mesoblast's Innovative Adult Mesenchymal Precursor Stem Cell Technology
- Forums
- ASX - By Stock
- MSB
- Pick Today's Price Range Low-High... Just for Fun
Pick Today's Price Range Low-High... Just for Fun, page-57
-
- There are more pages in this discussion • 1,267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B |
Open | High | Low | Value | Volume |
$1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 36989 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | 1.240 |
2 | 45159 | 1.235 |
4 | 42275 | 1.230 |
1 | 15746 | 1.225 |
5 | 56349 | 1.220 |
Price($) | Vol. | No. |
---|---|---|
1.245 | 36989 | 4 |
1.250 | 118007 | 15 |
1.255 | 236249 | 7 |
1.260 | 440345 | 9 |
1.265 | 67045 | 4 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |